A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone

Phase 3

Terminated

• Conditions: Lung Disease; Pulmonary Fibrosis

• Registration Number: NCT00052039
• Lead Sponsor: InterMune

Brief Summary

Study GIPF-003 is a Phase 3b study designed to define better therapeutic use of IFN-gamma 1b in patients wtih IPF. The study will be conducted primarily in Europe and will enroll 210 patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2002-04
• Study Completion: 2002-06
• Study First Submitted: 2003-01-21
• Study First Submitted QC: 2003-01-21
• Study First Posted: 2003-01-22
• Status Verified: 2007-11
• Last Update Submitted: 2007-11-02
• Last Update Posted: 2007-11-06

Recruitment & Eligibility

• Status: TERMINATED
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
This study was terminated prior to enrollment.	This study was terminated prior to enrollment.

Trial Locations

Locations (1)

Ospedale S. Luigi Gonzaga - Regione; 🇮🇹 Torino, Orbassano, Italy